Skip to content

Efficacy of Fu's Subcutaneous Needling Combined with Mulligan Dynamic Joint Mobilization in Patients with Chronic Nonspecific Low Back Pain

Efficacy of Fu's Subcutaneous Needling Combined with Mulligan Dynamic Joint Mobilization in Patients with Chronic Nonspecific Low Back Pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002200
Enrollment
Unknown
Registered
2025-11-17
Start date
2025-11-15
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Nonspecific Low Back Pain

Interventions

Intervention Group:Fu's Subcutaneous Needling with 24h tube retention and concurrent Mulligan MWM (20min/session) was administered to identified affected muscles 5x/week for 3 weeks.
Control Group:Mulligan MWM (20min/session) once daily, five times weekly for three weeks.

Sponsors

Jinniu District TCM Hospital Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: According to the 2020 Evidence-Based Clinical Guidelines for the Diagnosis of Nonspecific Low Back Pain issued by the North American Spine Society (NASS) the inclusion criteria were: Age 30-70 years old; Presence of somatic referred pain confined to regions proximal to the knee consistent with non-radicular pain patterns; Pain duration = 12 weeks.

Exclusion criteria

Exclusion criteria: Exclusion Criteria:Specific low back pain secondary to malignancies infections fractures or metabolic disorders;Spinal deformities including spondylolisthesis and scoliosis;Extraspinal pathologies (e.g. visceral vascular reproductive or urological diseases);History of lumbar spine surgery;Patients with neurological deficits;Low back pain with =2 concomitant pain sites; Severe systemic diseases pregnancy/lactation psychiatric disorders cognitive impairment or inability to comply with the trial.

Design outcomes

Primary

MeasureTime frame
Oswestry Disability Index;

Secondary

MeasureTime frame
Visual Analog Scale;Roland-Morris Disability Questionnaire;

Countries

China

Contacts

Public ContactZeng Li

Jinniu District TCM Hospital Chengdu

54189772@qq.com+86 13982020309

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026